Ng ML, Yap AT. (2002), «Inhibition of human colon carcinoma development by lentinan from shiitake mushrooms (Lentinus edodes).», National University of Singapore, J Altern Complement Med., 8 (5): 581–9, PMID12470439, doi:10.1089/107555302320825093
Yang P, Liang M, Zhang Y, Shen B. (2008), «Clinical application of a combination therapy of lentinan, multi-electrode RFA and TACE in HCC.», Adv Ther., 25 (8): 787–94, PMID18670743, doi:10.1007/s12325-008-0079-x !CS1 manut: Nomes múltiplos: lista de autores (link)
Ng ML, Yap AT. (2002), «Inhibition of human colon carcinoma development by lentinan from shiitake mushrooms (Lentinus edodes).», National University of Singapore, J Altern Complement Med., 8 (5): 581–9, PMID12470439, doi:10.1089/107555302320825093
Yang P, Liang M, Zhang Y, Shen B. (2008), «Clinical application of a combination therapy of lentinan, multi-electrode RFA and TACE in HCC.», Adv Ther., 25 (8): 787–94, PMID18670743, doi:10.1007/s12325-008-0079-x !CS1 manut: Nomes múltiplos: lista de autores (link)
Nimura H, Mitsumori N, Takahashi N, (2006), «[S-1 combined with lentinan in patients with unresectable or recurrent gastric cancer]», Gan to Kagaku Ryoho., 33 (1): 106–9, PMID16897983 !CS1 manut: Nomes múltiplos: lista de autores (link)
Nakano H, Namatame K, Nemoto H, Motohashi H, Nishiyama K, Kumada K. (1999), «A multi-institutional prospective study of lentinan in advanced gastric cancer patients with unresectable and recurrent diseases: effect on prolongation of survival and improvement of quality of life. Kanagawa Lentinan Research Group.», Hepatogastroenterology., 46 (28): 2662–8, PMID10522061 !CS1 manut: Nomes múltiplos: lista de autores (link)
Oba K, Kobayashi M, Matsui T, Kodera Y, Sakamoto J (2009). «Individual Patient Based Meta-analysis of Lentinan for Unresectable/Recurrent Gastric Cancer». Anticancer Res. 29 (7): 2739–45. PMID19596954 !CS1 manut: Nomes múltiplos: lista de autores (link)
Hazama S, Watanabe S, Ohashi M; et al. (2009). «Efficacy of Orally Administered Superfine Dispersed Lentinan ({beta}-1,3-Glucan) for the Treatment of Advanced Colorectal Cancer». Anticancer Res. 29 (7): 2611–7. PMID19596936 !CS1 manut: Uso explícito de et al. (link) !CS1 manut: Nomes múltiplos: lista de autores (link)
Kataoka H, Shimura T, Mizoshita T; et al. (2009). «Lentinan with S-1 and paclitaxel for gastric cancer chemotherapy improve patient quality of life». Hepatogastroenterology. 56 (90): 547–50. PMID19579640 !CS1 manut: Uso explícito de et al. (link) !CS1 manut: Nomes múltiplos: lista de autores (link)
Isoda N, Eguchi Y, Nukaya H; et al. (2009). «Clinical efficacy of superfine dispersed lentinan (beta-1,3-glucan) in patients with hepatocellular carcinoma». Hepatogastroenterology. 56 (90): 437–41. PMID19579616 !CS1 manut: Uso explícito de et al. (link) !CS1 manut: Nomes múltiplos: lista de autores (link)
Shimizu K, Watanabe S, Watanabe S; et al. (2009). «Efficacy of oral administered superfine dispersed lentinan for advanced pancreatic cancer». Hepatogastroenterology. 56 (89): 240–4. PMID19453066 !CS1 manut: Uso explícito de et al. (link) !CS1 manut: Nomes múltiplos: lista de autores (link)